$Unique_ID{BRK03987} $Pretitle{} $Title{Meige Syndrome} $Subject{Meige Syndrome Brueghel syndrome Blepharospasm Oromandibular Dystonic syndrome } $Volume{} $Log{} Copyright (C) 1986, 1990 National Organization for Rare Disorders, Inc. 235: Meige Syndrome ** IMPORTANT ** It is possible the main title of the article (Meige Syndrome) is not the name you expected. Please check the SYNONYMS listing to find the alternate names and disorder subdivisions covered by this article. Synonyms Brueghel syndrome Blepharospasm Oromandibular Dystonic syndrome General Discussion ** REMINDER ** The information contained in the Rare Disease Database is provided for educational purposes only. It should not be used for diagnostic or treatment purposes. If you wish to obtain more information about this disorder, please contact your personal physician and/or the agencies listed in the "Resources" section of this report. Meige syndrome is a neurological movement disorder. It is characterized by abnormal jerky movements of the muscles of the face, jaw, eyebrows and spasm of the muscle around the eye. There may also be tongue, throat, and possible respiratory spasms. Symptoms Meige syndrome is characterized by impaired voluntary movements (dyskinesia), ceaseless rapid involuntary jerky movements (chorea), and disordered tension of all muscles (dystonia) of the facial musculature such as the jaws and the eyebrows. Rapid eye blinking and spasms of the muscles around the eye (blepharospasm) can cause the inability to control movement of the eyelids, resulting in involuntary closure of the eyes intermittently. The trunk and the extremities may be involved, but this is less common than facial involvement. Tongue, throat, and possible respiratory system spasms may also occur. Onset of Meige's syndrome is gradual, occurring usually in individuals over 50 years of age. Causes The specific cause of this neurological movement disorder is not known. Malfunction of brain chemicals (neurotransmitters) has been implicated in Meige's syndrome. Affected Population Meige's syndrome usually affects people over 50 years of age although it can occur at younger ages. Related Disorders Benign Essential Blepharospasm is a disorder affecting the circular muscle around the eye. It is characterized by strong involuntary contractions of this muscle resulting in intermittent loss of control over eyelid movements. The blepharospasm is similar, but other facial muscles are also involved in Meige's syndrome. (For more information on blepharospasm, choose Benign Essential Blepharospasm as your search term in the Rare Disease Database.) Therapies: Standard Drugs used to treat the blepharospasm of Meige syndrome include the following: a. diazepam, a tranquilizer b. levodopa, an anti-parkinsonian agent c. methyldopa, an antihypertensive d. trihexyphenidyl, an anticholinergic e. lithium (which is also used to treat manic depression) f. baclofen (Lioresal), a muscle relaxant g. clonazepam (Clonopin), an anticonvulsant Therapies: Investigational Botulinum A Toxin is being used experimentally on Meige Syndrome. This orphan drug (brand name Oculinum) is injected into muscles in order to halt spasms by temporarily paralyzing the muscle. Treatment must be repeated within a few months when the spasms return. This disease entry is based upon medical information available through April 1990. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder. Resources For more information on Meige Syndrome, please contact: National Organization for Rare Disorders (NORD) P.O. Box 8923 New Fairfield, CT 06812-1783 (203) 746-6518 NIH/National Institute of Neurological Disorders & Stroke (NINDS) 9000 Rockville Pike Bethesda, MD 20892 (301) 496-5751 (800) 352-9424 Dystonia Medical Research Foundation 8383 Wilshire Blvd. Beverly Hills, CA 90211 (213) 852-1630 Dystonia Medical Research 1 E. Wacker Dr., Suite 2900 Chicago, IL 60601-20998 Benign Essential Blepharospasm Research Foundation, Inc. (BEBRF, Inc.) P.O. Box 12468 Beaumont, TX 77726-2468 (409) 832-0788 References CECIL TEXTBOOK OF MEDICINE, 18th ed.: James B. Wyngaarden, and Lloyd H. Smith, Jr., Eds.: W. B. Saunders Co., 1988. Pp. 2150-1. THE MERCK MANUAL 15th ed: R. Berkow, et al: eds; Merck, Sharp & Dohme Research Laboratories, 1987. P. 1421.